https://www.sowetanlive.co.za/news/africa/2022-12-23-biontech-initiates-clinical-trial-of-mrna-based-malaria-vaccine-candidate/
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German company announced on Friday.
Create an account or login to join the discussion